top of page
Blackstone Life Sciences' $3.1BN sale of Anthos Therapeutics to Novartis
Novartis reacquires Anthos from Blackstone after cardiovascular drug abelacimab shows promise. A successful PE/Biopharma model emerges.
The Carlyle Group’s minority stake investment of Entertainment 360
Carlyle takes a minority stake in Entertainment 360— fueling growth in talent management & content production. PE reshapes entertaiment.
bottom of page